Form
Powder
Appearance
Whiteorlightyellowcrystallinepowder
Source
Synthetic
Assay
98.0%-102.0%
LossonDrying
≤1.0%
ResidueOnIgnition
≤0.1%
HeavyMetals
≤20ppm
Impurities
Fluoroquinolinicacid:≤0.2%
Ciprofloxacinisasecondgenerationfluoroquinoloneantibiotic.
TOKU-Eofferstwoformsofciprofloxacin:ciprofloxacin(C031)andciprofloxacinHCl(C032).Ciprofloxacinissparinglysolubleinaqueoussolution(1.1µg/mL).CiprofloxacinHClisfreelysolubleat35mg/mL.
85721-33-1
C17H18FN3O3
331.34g/mol
FluoroquinoloneantibioticstargetbacterialDNAgyrase,anenzymewhichreducesDNAstrainduringreplication.BecauseDNAgyraseisrequiredduringDNAreplication,subsequentDNAsynthesisandcelldivisionisinhibited.
2-8°C,protectfromlight
2933.59.3600
Ciprofloxacinisabroadspectrumantibiotictargetingawidevarietyofgrampositiveandgramnegativebacteria.
Powder
Whiteorlightyellowcrystallinepowder
Synthetic
98.0%-102.0%
≤1.0%
≤0.1%
≤20ppm
Fluoroquinolinicacid:≤0.2%